Welcome to our dedicated page for Adapthealth SEC filings (Ticker: AHCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles SEC filings for AdaptHealth Corp. (NASDAQ: AHCO), a company that describes itself as a national provider of patient-centered, healthcare-at-home solutions. Its common stock is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades on The Nasdaq Stock Market LLC under the ticker AHCO, as disclosed in its current reports.
AdaptHealth’s recent regulatory filings include multiple current reports on Form 8-K. These filings furnish press releases announcing quarterly financial results for periods ended June 30 and September 30, along with updates to financial guidance and information on the closing of dispositions of certain assets in its Wellness at Home segment. The 8-Ks also cover a new capitated partnership with a large integrated delivery network and provide details on the company’s annual meeting of stockholders, including votes on director elections, auditor ratification, and advisory approval of executive compensation.
Through these filings, readers can review how AdaptHealth reports net revenue, net income, and cash flow, and how it discusses non-GAAP measures such as EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, free cash flow, and organic revenue. The company explains in its press releases, furnished as exhibits to the 8-Ks, how these metrics are used in its operational and financial decision-making and how they relate to its credit agreements.
Stock Titan’s SEC filings page presents these AdaptHealth documents with AI-powered summaries that highlight key items, such as earnings announcements, guidance changes, asset sales, and partnership disclosures. Users can quickly locate 8-Ks and related exhibits, and track how the company communicates material events, capital structure developments, and governance matters through the EDGAR system.
AdaptHealth Corp. director Theodore B. Lundberg reported acquiring 13,740 shares of AdaptHealth common stock on January 9, 2026. The filing shows the shares were received at a price of $0 per share and are described as restricted stock units that will be settled in common stock upon vesting. Following this transaction, Lundberg is shown as beneficially owning 873,496 shares of AdaptHealth common stock with direct ownership.
AdaptHealth Corp. director Gregory Belinfanti reported an equity award in the form of restricted stock units. On January 9, 2026, he was granted 11,776 shares of AdaptHealth common stock at a reported price of $0 per share, reflecting a compensatory award rather than an open‑market purchase. These shares are structured as restricted stock units that will be settled in common stock when they vest. Following this grant, Belinfanti directly beneficially owned 85,270 shares of AdaptHealth common stock.
AdaptHealth Corp. director David S. Williams III reported an open-market sale of 5,000 shares of the company’s common stock on December 4, 2025 at a price of $9.43 per share. After this transaction, he beneficially owns 45,045 shares of AdaptHealth common stock, held directly.
AdaptHealth Corp. (AHCO) reported Q3 2025 results. Net revenue was $820.3 million versus $805.9 million a year ago. Operating income was $61.7 million, and net income attributable to AdaptHealth was $24.5 million, or diluted EPS of $0.16 (vs. $0.15). Segment revenue totaled $354.8 million in Sleep Health, $177.0 million in Respiratory Health, $150.1 million in Diabetes Health, and $138.4 million in Wellness at Home.
On the balance sheet, long‑term debt (less current) was $1.74 billion and cash was $80.4 million as of September 30, 2025. Year‑to‑date, operating cash flow was $418.6 million, with a $32.2 million pre‑tax gain from the sale of two businesses closed on May 1 and June 9, 2025. For the nine months, depreciation and amortization (including patient equipment) was $284.4 million. As of October 31, 2025, there were 135,424,334 common shares outstanding.
David S. Williams III, a director of AdaptHealth Corp. (AHCO), sold 8,200 shares on 08/22/2025 at a weighted average price of $9.73 per share. The filing shows the reported sales occurred in multiple transactions at prices ranging from $9.60 to $9.85, and the reporting person continues to beneficially own 50,045 shares following the transactions. The Form 4 was filed by one reporting person and signed by an attorney-in-fact, with a previously filed power of attorney incorporated by reference.
AdaptHealth Corp. 10-Q (Q2 2025) Reports net revenue of $800.4M for Q2 2025 and $1.578B for the six months ended June 30, 2025, relative to $806.0M and $1.598B a year earlier.
Operating income improved to $79.3M in Q2 driven by a $32.225M gain on sale of businesses; however, higher income tax expense ($35.9M in Q2) contributed to a Q2 net income of $15.8M and six-month net income of $9.7M, down vs. prior periods.
- Adjusted EBITDA declined to $155.5M in Q2 and to $283.5M for six months.
- Cash declined to $68.63M from $109.75M at year-end.
- Long-term debt decreased to $1.793B from $1.965B (repayments of $175.0M noted).
- Disposed two Wellness at Home businesses for gross proceeds of $120.835M and recognized related goodwill reductions.
FAQ
What is the current stock price of Adapthealth (AHCO)?
What is the market cap of Adapthealth (AHCO)?
